Metraipolis › archive › dc_bbcc4acb1071

Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR… — Europe PMC PMID:42311561

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42311561
DOI
10.1002/osp4.70159
License (as archived)
solo-consultazione
Archived
2026-10-19T09:31:05.306Z
SHA-256 of the archived text
6739633eea1d0595e540c427af3b9299d5fc1d030b83683636592fc71e1539b4
Stable URL of this page
https://metraipolis.com/documento/dc_bbcc4acb1071

How to cite

Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR… — Europe PMC PMID:42311561 — Europe PMC (en), https://europepmc.org/article/MED/42311561 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bbcc4acb1071 (Metraipolis archive dc_bbcc4acb1071, sha256 6739633eea1d0595e540c427af3b9299d5fc1d030b83683636592fc71e1539b4)
BibTeX
@misc{dcbbcc4acb1071,
  title = {Identifying Predictors of Weight-Related Outcomes With Fixed-Dose, Extended-Release Naltrexone and Bupropion Among Treatment-Adherent Patients in Phase 3 COR… — Europe PMC PMID:42311561},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42311561},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bbcc4acb1071; sha256 6739633eea1d0595e540c427af3b9299d5fc1d030b83683636592fc71e1539b4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42311561. Agents can read the archived copy with the MCP tool read_document.